Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas.
The role of the CDKN2A (p16INK4a) gene in sporadic primary melanomas has remained unclear due to the inadequate number of mutational studies. In the present study, we analyzed the entire coding region of the CDKN2A gene in microdissected sporadic primary melanomas, for the presence of mutations and polymorphisms, using 2 independent methods of mutation detection, SSCP and CMC. We found 11 intragenic mutations in 8 melanomas out of 31 (26%) and the majority of mutations were located in exon 1, with 2 cases harbouring multiple mutations. Of the mutations detected, 6 were C-to-T transitions, 4 involving CC sites; 2 melanomas showed a novel deletion of one of the two 24-bp repeat units located at the 5' end of exon 1. There was also a high frequency of C-to-G and C-to-T polymorphisms at the nucleotides 540 (frequency of G allele: 0.18) and 580 (frequency of T allele: 0.13) in the 3' untranslated region.
Kumar
R
R
Center for Nutrition and Toxicology, Karolinska Institute, Huddinge, Sweden. rajiv.kumar@cnt.ki.se
Lundh Rozell
B
B
Louhelainen
J
J
Hemminki
K
K
D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics*; D004210:Dissection; D006801:Humans; D008545:Melanoma / Q000235:genetics*; D009154:Mutation; D011110:Polymorphism, Genetic; D012878:Skin Neoplasms / Q000235:genetics*
D019941:Cyclin-Dependent Kinase Inhibitor p16